TY - JOUR T1 - The epidemiology of Mayaro virus in the Americas: A systematic review and key parameter estimates for outbreak modelling JF - medRxiv DO - 10.1101/2020.12.10.20247296 SP - 2020.12.10.20247296 AU - Edgar-Yaset Caicedo AU - Kelly Charniga AU - Amanecer Rueda AU - Ilaria Dorigatti AU - Yardany Mendez AU - Arran Hamlet AU - Jean-Paul Carrera AU - Zulma M. Cucunubá Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/11/2020.12.10.20247296.abstract N2 - Mayaro virus (MAYV) is an arbovirus that is endemic to tropical forests in Central and South America, particularly within the Amazon basin. In recent years, concern has increased regarding MAYV’s ability to invade urban areas and cause epidemics across the region. We conducted a systematic literature review to characterise the evolutionary history of MAYV, its transmission potential, and exposure patterns to the virus. We analysed data from the literature on MAYV infection to produce estimates of key epidemiological parameters, including the generation time and the basic reproduction number, R0. We also estimated the force-of-infection (FOI) in epidemic and endemic settings. Seventy-six publications met our inclusion criteria. Evidence of MAYV infection in humans, animals, or vectors was reported in 14 Latin American countries. Nine countries reported evidence of acute infection in humans confirmed by viral isolation or reverse transcription-PCR (RT-PCR). We identified at least five MAYV outbreaks. Seroprevalence from population based cross-sectional studies ranged from 21% to 72%. The estimated mean generation time of MAYV was 15.2 days (95% CrI: 11.7-19.8) with a standard deviation of 6.3 days (95% CrI: 4.2-9.5). The per-capita risk of MAYV infection (FOI) ranged between 0.01 and 0.05 per year, producing R0 estimates between 1.1 and 2.9 in endemic settings. In an outbreak in Santa Cruz, Bolivia, R0 was estimated at 2.2 (95% CrI: 0.8-4.8). Although MAYV has been identified in urban vectors, there is not yet evidence of sustained urban transmission. MAYV’s enzootic cycle could become established in forested areas within cities similar to yellow fever virus.Author summary Each year, diseases that are transmitted by mosquitoes cause substantial deaths and disability across the world. We performed a systematic literature review of Mayaro virus (MAYV) and estimated key epidemiological parameters that can be used to improve future outbreak response. We estimated the generation time and basic reproduction number for a historical outbreak. Our results suggest that the force-of-infection of MAYV in endemic settings is low. We did not find evidence of substantial urban transmission of MAYV. Nevertheless, similarities between MAYV and yellow fever virus epidemiology suggest that MAYV could emerge in urban areas. Local transmission of MAYV has never been reported outside of Central and South America. Our results highlight the need to continue monitoring emerging arboviruses in the Americas.Competing Interest StatementThe authors have declared no competing interest.Funding StatementEYC is funded by a young researcher grant (Joven Investigador) UPTC, call No. 018 2018. ZMC is funded by the MRC/Rutherford Fund Research Fund (grant MR/R024855/1). ZMC, ID and KC jointly acknowledge the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union (grant MR/R015600/1). KC is funded by Imperial College London Presidents PhD Scholarship. ID acknowledges research funding from a Sir Henry Dale fellowship funded by Wellcome Trust and The Royal Society (grant 213494/Z/18/Z). JPC is funded by the Clarendon Scholarship from University of Oxford and Lincoln-Kingsgate Scholarship from Lincoln College, University of Oxford (grant number SFF1920_CB2_MPLS_1293647).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript is a systematic review of literature, IRB approval is not necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll information has made available within the main document and supplementary material ER -